DOCUMENT_1 = """
<DOCTYPE html>
  <html lang="en">
    <head>
      <meta charset="UTF-8" />
      <meta name="viewport" content="width=device-width, initial-scale=1.0" />
      <title>Wireless optogenetic device for remotely controlling neural activitiies</title>
    </head>
    <body>
      <h1>Claims</h1>
      <p>
        1. A wireless optogenetic device for remotely controlling neural
        activities, the device comprising:
      </p>
      <p>
        a body holding light transducing materials capable of up-converting
        infrared or near-infrared electromagnetic radiation to visible light,
        wherein the body is made of biocompatible materials and is transparent
        and lightweight;
      </p>
      <p>
        the light transducing materials being lanthanide-doped nanoparticles or
        similar, capable of up-converting infrared or near-infrared to visible
        light;
      </p>
      <p>
        a device being designed to be placed near a neural cell of a subject,
        and having a tapered design for concentrated light emission;
      </p>
      <p>
        the device further comprising multiple optical windows for complex
        neural activity control, and being sealed to enclose the light
        transducing materials.
      </p>
      <p>
        2. The wireless optogenetic device of claim 1, wherein the biocompatible
        materials are glass or polydimethylsiloxane.
      </p>
      <p>
        3. The wireless optogenetic device of claim 1, wherein the device is
        adaptable for both human and non-human subjects.
      </p>
      <p>
        4. A radiation system for remotely activating the wireless optogenetic
        device of claim 1, the radiation system comprising:
      </p>
      <p>
        a radiation probe, a movement mechanism, a detector, and a controller;
      </p>
      <p>
        the radiation system being capable of tracking and irradiating the
        wireless device with infrared or near-infrared radiation, enabling
        real-time adjustment and precise targeting;
      </p>
      <p>
        the radiation system being capable of altering properties of radiation
        including wavelength, intensity, and pulse duration, and being adaptable
        to various subject movement ranges.
      </p>
      <p>
        5. The radiation system of claim 4, wherein the system's versatility
        allows for various experimental settings and subject conditions.
      </p>
      <p>
        6. A method for remotely controlling neural activities, the method
        having the steps of:
      </p>
      <p>
        placing the wireless optogenetic device of claim 1 near a neural cell of
        a subject;
      </p>
      <p>
        activating the wireless optogenetic device using the radiation system of
        claim 4;
      </p>
      <p>
        up-converting infrared or near-infrared electromagnetic radiation to
        visible light using the light transducing materials in the wireless
        optogenetic device;
      </p>
      <p>
        controlling complex neural activity through the multiple optical windows
        in the wireless optogenetic device.
      </p>
      <p>
        7. The method of claim 5, wherein the step of activating the wireless
        optogenetic device includes tracking and irradiating the wireless device
        with infrared or near-infrared radiation, enabling real-time adjustment
        and precise targeting.
      </p>
      <p>
        8. The method of claim 6, wherein the step of activating the wireless
        optogenetic device includes altering properties of radiation including
        wavelength, intensity, and pulse duration.
      </p>
        </body>
  </html>
</DOCTYPE>
"""

DOCUMENT_2 = """
<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Microfluidic Device for Blood Oxygenation</title>
  </head>
  <body>
    <h1>Claims</h1>
    <p>
      1. A microfluidic device for blood oxygenation, the device consisting:
    </p>
    <p>a first flow channel configured to carry blood;</p>
    <p>the second flow channel configured to carry oxygen;</p>
    <p>
      a gas-permeable membrane, the membrane being made of glass and configured
      to allow oxygen to permeate from the second flow channel into the first
      flow channel while preventing blood components from crossing into the
      second flow channel;
    </p>
    <p>a polymer substrate housing the first and second flow channels; and</p>
    <p>
      mixing elements located within the second flow channel, the mixing
      elements being configured to facilitate the exposure of blood to the
      gas-permeable membrane.
    </p>
    <p>
      2. The microfluidic device of claim 1, wherein the polymer substrate is
      made from a material selected from the group consisting of polystyrene,
      polyimide, polycaprolactone, polyglycerol sebacate, polydimethylsiloxane,
      poly(N-isopropylacrylamide), ceramics, metals, glasses, and carbon or zinc
      oxide-based nanotubes or nanowires.
    </p>
    <p>
      3. A microfluidic device of claim 1 wherein the mixing elements are in the
      form of ridges, channels, or protrusions.
    </p>
    <p>
      4. The microfluidic device of claim 1, wherein the mixing elements cover
      the full length of the second flow channel.
    </p>
    <p>
      5. The microfluidic device of claim 1, wherein the mixing elements cover a
      portion of the length of the second flow channel.
    </p>
    <p>
      6. The microfluidic device of claim 1, wherein multiple types of mixing
      elements are used in the same device.
    </p>
    <p>
      7. A method of oxygenating blood using the microfluidic device of claim 1,
      the method comprising the steps of:
    </p>
    <p>
      introducing partially deoxygenated blood into the first flow channel at a
      starting end of the device;
    </p>
    <p>directing oxygen through the second flow channel;</p>
    <p>
      allowing the blood to pass the gas-permeable membrane and encounter the
      mixing elements, thereby oxygenating the blood; and
    </p>
    <p>collecting the oxygen-rich blood at an exit end of the device.</p>
    <p>
      8. The method of claim 7, wherein the device requires less blood to start
      the oxygenation process compared to prior art devices.
    </p>
    <p>
      9. The method of claim 7, wherein the device is adapted for various
      applications due to its design flexibility.
    </p>
      </body>
</html>
"""
